The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary.
The number of Americans aged 65 and older with Alzheimer's disease (AD) is expected to more than double from 6.2 million today to 12.7 million by 2050.
Responding to a record number of drug overdose deaths in the United States, Pfizer has made a commitment to Direct Relief to donate 1 million doses of the drug naloxone, which saves lives by reversing opioid overdoses.
The Naval Medical Research Center (NMRC) and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
3M Health Care launched 3M™ Polisher™ ST,* an advanced, single-use AEX solution designed to replace reusable AEX polishing column for biologic drug manufacturing.
Caliper Ingredients (Caliper), a leading manufacturer and supplier of soluble cannabinoid ingredients, in conjunction with Colorado State University (CSU), has completed the CBD industry's first human clinical study of commercially available CBD-infused food and supplement product pharmacokinetics.
Pharmacists & technicians at Precision LTC Pharmacy conducted a seamless distribution of the Moderna COVID-19 vaccine to over 200 individuals & staff from Maryhaven Center of Hope last Wednesday.
Golden Biotechnology Corp.(TPEx:4132)("GoldenBiotech"), a leading Taiwanese biopharmaceutical company, announced that it has made two achievements for its Covid-19
Chengdu Kanghong Pharmaceutical Group ("Kanghong", SHE: 002773), has received Special Protocol Assessments from the Food and Drug Administration for three new indications for its biologic drug conbercept. The drug is an anti-VEGF fusion protein, approved and marketed in China as Lumitin®, for the treatment of retinal diseases.
The Feinstein Institutes for Medical Research and Cold Spring Harbor Laboratory (CSHL) are recruiting patients in a fully virtual, in-home, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of famotidine, or PEPCID, for the outpatient treatment of the novel coronavirus disease 2019 (COVID-19) in adults.